| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8925329 | Journal of Gynecology Obstetrics and Human Reproduction | 2017 | 6 Pages |
Abstract
When a cervical cancer screening by HPV or cytology is not possible, VIA remains a feasible and acceptable option in a disadvantaged environment. The effectiveness of this approach is still limited by the problems of access to care for patients who are not eligible for immediate treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
A. Dumont, N. Bessières, A. Benbassa, G. Razafindrafara, F. Rabearison, H.-J. Philippe,